Anti-FANCM monoclonal antibody

Pre-made anti-FANCM monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FANCM/FANCM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0831-Ab-1/ GM-Tg-hg-IP0831-Ab-2Anti-Human FANCM monoclonal antibodyHuman
GM-Tg-rg-IP0831-Ab-1/ GM-Tg-rg-IP0831-Ab-2Anti-Rat FANCM monoclonal antibodyRat
GM-Tg-mg-IP0831-Ab-1/ GM-Tg-mg-IP0831-Ab-2Anti-Mouse FANCM monoclonal antibodyMouse
GM-Tg-cynog-IP0831-Ab-1/ GM-Tg-cynog-IP0831-Ab-2Anti-Cynomolgus/ Rhesus macaque FANCM monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0831-Ab-1/ GM-Tg-felg-IP0831-Ab-2Anti-Feline FANCM monoclonal antibodyFeline
GM-Tg-cang-IP0831-Ab-1/ GM-Tg-cang-IP0831-Ab-2Anti-Canine FANCM monoclonal antibodyCanine
GM-Tg-bovg-IP0831-Ab-1/ GM-Tg-bovg-IP0831-Ab-2Anti-Bovine FANCM monoclonal antibodyBovine
GM-Tg-equg-IP0831-Ab-1/ GM-Tg-equg-IP0831-Ab-2Anti-Equine FANCM monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0831-Ab-1/ GM-Tg-hg-IP0831-Ab-2; GM-Tg-rg-IP0831-Ab-1/ GM-Tg-rg-IP0831-Ab-2;
GM-Tg-mg-IP0831-Ab-1/ GM-Tg-mg-IP0831-Ab-2; GM-Tg-cynog-IP0831-Ab-1/ GM-Tg-cynog-IP0831-Ab-2;
GM-Tg-felg-IP0831-Ab-1/ GM-Tg-felg-IP0831-Ab-2; GM-Tg-cang-IP0831-Ab-1/ GM-Tg-cang-IP0831-Ab-2;
GM-Tg-bovg-IP0831-Ab-1/ GM-Tg-bovg-IP0831-Ab-2; GM-Tg-equg-IP0831-Ab-1/ GM-Tg-equg-IP0831-Ab-2
Products NameAnti-FANCM monoclonal antibody
Formatmab
Target NameFANCM
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FANCM monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0831-Ag-1Recombinant multi-species FANCM/ FAAP250/ KIAA1596 protein


    Target information

    Target IDGM-IP0831
    Target NameFANCM
    Gene ID57697,104806,314172,702513,480307,101086570,513626,100063761
    Gene Symbol and SynonymsC730036B14Rik,D12Ertd364e,FAAP250,FANCM,KIAA1596,POF15,RGD1307897,SPGF28
    Uniprot AccessionQ8IYD8
    Uniprot Entry NameFANCM_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000187790
    Target ClassificationTumor-associated antigen (TAA)

    The target: FANCM, gene name: FANCM, also named as FAAP250, KIAA1596, POF15, SPGF28. The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.